JP2005528398A5 - - Google Patents

Download PDF

Info

Publication number
JP2005528398A5
JP2005528398A5 JP2003584049A JP2003584049A JP2005528398A5 JP 2005528398 A5 JP2005528398 A5 JP 2005528398A5 JP 2003584049 A JP2003584049 A JP 2003584049A JP 2003584049 A JP2003584049 A JP 2003584049A JP 2005528398 A5 JP2005528398 A5 JP 2005528398A5
Authority
JP
Japan
Prior art keywords
per
blood
antidiabetic
average
recorded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003584049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005528398A (ja
JP4309769B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2002/000105 external-priority patent/WO2003087093A1/en
Publication of JP2005528398A publication Critical patent/JP2005528398A/ja
Publication of JP2005528398A5 publication Critical patent/JP2005528398A5/ja
Application granted granted Critical
Publication of JP4309769B2 publication Critical patent/JP4309769B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003584049A 2002-04-08 2002-04-08 新規なグルコピラノサイド、その分離方法、それを含む薬物及びその使用方法 Expired - Fee Related JP4309769B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000105 WO2003087093A1 (en) 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Publications (3)

Publication Number Publication Date
JP2005528398A JP2005528398A (ja) 2005-09-22
JP2005528398A5 true JP2005528398A5 (https=) 2009-05-07
JP4309769B2 JP4309769B2 (ja) 2009-08-05

Family

ID=29227416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003584049A Expired - Fee Related JP4309769B2 (ja) 2002-04-08 2002-04-08 新規なグルコピラノサイド、その分離方法、それを含む薬物及びその使用方法

Country Status (7)

Country Link
EP (1) EP1495019B1 (https=)
JP (1) JP4309769B2 (https=)
CN (1) CN1280290C (https=)
AT (1) ATE399778T1 (https=)
AU (1) AU2002246317A1 (https=)
DE (1) DE60227421D1 (https=)
WO (1) WO2003087093A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2567571T3 (es) 2003-03-14 2016-04-25 Astellas Pharma Inc. Derivados de C-glucósido y sales de los mismos
EP1679965A4 (en) 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES
RS20060320A (sr) 2003-08-01 2008-08-07 Janssen Pharmaceutica N.V., Supstituisani indazol-o-glukozidi
TW200524951A (en) 2003-08-01 2005-08-01 Janssen Pharmaceutica Nv Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
EA010422B1 (ru) 2003-08-01 2008-08-29 Янссен Фармацевтика Н.В. Замещённые индол-о-глюкозиды
EP1724277A4 (en) * 2004-03-04 2012-05-02 Kissei Pharmaceutical ACCOLE HETEROCYCLIC DERIVATIVE, DRUG-CONTAINING COMPOSITION THEREOF, AND THE USE THEREOF
AU2005219779B2 (en) * 2004-03-04 2011-04-14 Kissei Pharmaceutical Co., Ltd. Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
KR101100072B1 (ko) 2006-12-21 2011-12-29 고토부키 세이야쿠 가부시키가이샤 C-글리코시드 유도체의 제조방법 및 이의 합성 중간체
TW201623321A (zh) 2014-05-13 2016-07-01 韓美藥品股份有限公司 雙環衍生物及包含其之藥學組成物
CN106674311B (zh) * 2016-12-27 2019-02-05 西安交通大学 一种苯并呋喃苷类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627611B2 (en) * 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents

Similar Documents

Publication Publication Date Title
JP2003503454A5 (https=)
JP2005524658A5 (https=)
JP2005518413A5 (https=)
WO2003037864A1 (en) Indole compound and medicinal use thereof
JP2006526031A5 (https=)
JP2007514005A5 (https=)
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
JP2002511411A5 (https=)
JP2003520232A5 (https=)
EP2298416A3 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
JP2005528398A5 (https=)
EP1803710A4 (en) CONDENSED PYRIMIDINE DERIVATIVE CONTAINING NON-AROMATIC CYCLE
JP2008513510A5 (https=)
JP2007510699A5 (https=)
EP2072049A3 (en) Solid valsartan pharmaceutical compositions
JP2008516004A5 (https=)
JP2004532828A5 (https=)
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
JP2004517961A5 (https=)
NO20043483L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus
JP2007507472A5 (https=)
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
JP2002277470A5 (https=)
JP2005505605A5 (https=)
EP1132087A4 (en) REMEDIES FOR POLYKYSTIC OVARY SYNDROME